BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32905276)

  • 1. Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer.
    Roy S; Mohammad T; Gupta P; Dahiya R; Parveen S; Luqman S; Hasan GM; Hassan MI
    ACS Omega; 2020 Sep; 5(34):21550-21560. PubMed ID: 32905276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of sphingosine kinase 1 inhibitory potential of cinchonine and colcemid targeting anticancer therapy.
    Roy S; Khan S; Jairajpuri DS; Hussain A; Alajmi MF; Islam A; Luqman S; Parvez S; Hassan MI
    J Biomol Struct Dyn; 2022 Sep; 40(14):6350-6362. PubMed ID: 33565370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapy.
    Gupta P; Mohammad T; Khan P; Alajmi MF; Hussain A; Rehman MT; Hassan MI
    Biomed Pharmacother; 2019 Oct; 118():109245. PubMed ID: 31352240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and Development of Novel Urea, Sulfonyltriurea, and Sulfonamide Derivatives as Potential Inhibitors of
    Roy S; Mahapatra AD; Mohammad T; Gupta P; Alajmi MF; Hussain A; Rehman MT; Datta B; Hassan MI
    Pharmaceuticals (Basel); 2020 Jun; 13(6):. PubMed ID: 32526899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipophilic tail modifications of 2-(hydroxymethyl)pyrrolidine scaffold reveal dual sphingosine kinase 1 and 2 inhibitors.
    Li H; Sibley CD; Kharel Y; Huang T; Brown AM; Wonilowicz LG; Bevan DR; Lynch KR; Santos WL
    Bioorg Med Chem; 2021 Jan; 30():115941. PubMed ID: 33385956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of novel benzimidazole derivatives as sphingosine kinase 1 inhibitor.
    Khairat SHM; Omar MA; Ragab FAF; Roy S; Turab Naqvi AA; Abdelsamie AS; Hirsch AKH; Galal SA; Hassan MI; El Diwani HI
    Arch Pharm (Weinheim); 2021 Sep; 354(9):e2100080. PubMed ID: 34128259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of binding and inhibition mechanism of dietary phytochemicals with sphingosine kinase 1: Towards targeted anticancer therapy.
    Gupta P; Mohammad T; Dahiya R; Roy S; Noman OMA; Alajmi MF; Hussain A; Hassan MI
    Sci Rep; 2019 Dec; 9(1):18727. PubMed ID: 31822735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating potential of cholic acid, syringic acid, and mangiferin as cancer therapeutics through sphingosine kinase 1 inhibition.
    Shakeel I; Khan S; Roy S; Sherwani F; Ahmad SF; Sohal SS; Afzal M; Hassan MI
    Int J Biol Macromol; 2023 Dec; 253(Pt 5):127036. PubMed ID: 37788733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting inhibition of microtubule affinity regulating kinase 4 by Harmaline: Strategy to combat Alzheimer's disease.
    Adnan M; Anwar S; DasGupta D; Patel M; Elasbali AM; Alhassan HH; Shafie A; Siddiqui AJ; Bardakci F; Snoussi M; Hassan MI
    Int J Biol Macromol; 2023 Jan; 224():188-195. PubMed ID: 36257368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1beta and TNF-alpha induced production of inflammatory mediators.
    Billich A; Bornancin F; Mechtcheriakova D; Natt F; Huesken D; Baumruker T
    Cell Signal; 2005 Oct; 17(10):1203-17. PubMed ID: 16038795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect and mechanism of sphingosine kinase-1 knockdown on non-small cell lung cancer cell proliferation and mitochondrial apoptotic pathway].
    Cao YH; Yin W; Lyu YR
    Sheng Li Xue Bao; 2021 Dec; 73(6):893-900. PubMed ID: 34961863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer.
    Matula K; Collie-Duguid E; Murray G; Parikh K; Grabsch H; Tan P; Lalwani S; Garau R; Ong Y; Bain G; Smith AD; Urquhart G; Bielawski J; Finnegan M; Petty R
    BMC Cancer; 2015 Oct; 15():762. PubMed ID: 26493335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer.
    Song L; Xiong H; Li J; Liao W; Wang L; Wu J; Li M
    Clin Cancer Res; 2011 Apr; 17(7):1839-49. PubMed ID: 21325072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Caryophyllene from Chilli Pepper Inhibits the Proliferation of Non-Small Cell Lung Cancer Cells by Affecting miR-659-3p-Targeted Sphingosine Kinase 1 (SphK1).
    Lei J; Wang Q; Li G; Li Y; Zhang P; Xu G
    Int J Gen Med; 2021; 14():9599-9613. PubMed ID: 34916840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Sphingosine Kinase-1 Inhibitors from Bioactive Natural Products Targeting Cancer Therapy.
    Jairajpuri DS; Mohammad T; Adhikari K; Gupta P; Hasan GM; Alajmi MF; Rehman MT; Hussain A; Hassan MI
    ACS Omega; 2020 Jun; 5(24):14720-14729. PubMed ID: 32596609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1.
    Schnute ME; McReynolds MD; Kasten T; Yates M; Jerome G; Rains JW; Hall T; Chrencik J; Kraus M; Cronin CN; Saabye M; Highkin MK; Broadus R; Ogawa S; Cukyne K; Zawadzke LE; Peterkin V; Iyanar K; Scholten JA; Wendling J; Fujiwara H; Nemirovskiy O; Wittwer AJ; Nagiec MM
    Biochem J; 2012 May; 444(1):79-88. PubMed ID: 22397330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the substitution pattern of indole-based scaffold reveals potent and selective sphingosine kinase 2 inhibitors.
    Congdon M; Fritzemeier RG; Kharel Y; Brown AM; Serbulea V; Bevan DR; Lynch KR; Santos WL
    Eur J Med Chem; 2021 Feb; 212():113121. PubMed ID: 33445156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
    Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose.
    Huang K; Huang J; Chen C; Hao J; Wang S; Huang J; Liu P; Huang H
    Cell Signal; 2014 Mar; 26(3):629-38. PubMed ID: 24342046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of myeloperoxidase activity by the alkaloids of Peganum harmala L. (Zygophyllaceae).
    Bensalem S; Soubhye J; Aldib I; Bournine L; Nguyen AT; Vanhaeverbeek M; Rousseau A; Boudjeltia KZ; Sarakbi A; Kauffmann JM; Nève J; Prévost M; Stévigny C; Maiza-Benabdesselam F; Bedjou F; Van Antwerpen P; Duez P
    J Ethnopharmacol; 2014 Jun; 154(2):361-9. PubMed ID: 24746482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.